Prudential Financial Inc Regeneron Pharmaceuticals, Inc. Transaction History

Prudential Financial Inc

$70 Billion
Q3 2024

A detailed history of Prudential Financial Inc transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Prudential Financial Inc holds 69,563 shares of REGN stock, worth $48.9 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares

69,563

Previous 74,885 7.11%

Holding current value

$48.9 Million

Previous $78.7 Million 7.09%

% of portfolio

0.1%

Previous 0.12%

40 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$1024.09 - $1201.76 $5.45 Million - $6.4 Million	-5,322 Reduced 7.11%	69,563 $73.1 Million
Q2 2024 Aug 13, 2024	SELL	$883.2 - $1071.19 $951,206 - $1.15 Million	-1,077 Reduced 1.42%	74,885 $78.7 Million
Q1 2024 May 14, 2024	SELL	$902.69 - $993.35 $922,549 - $1.02 Million	-1,022 Reduced 1.33%	75,962 $73.1 Million
Q4 2023 Feb 13, 2024	SELL	$775.18 - $881.7 $11.8 Million - $13.4 Million	-15,201 Reduced 16.49%	76,984 $67.6 Million
Q3 2023 Nov 13, 2023	SELL	$692.45 - $844.37 $1.04 Million - $1.26 Million	-1,495 Reduced 1.6%	92,185 $75.9 Million
Q2 2023 Aug 11, 2023	SELL	$700.03 - $830.35 $8.05 Million - $9.55 Million	-11,501 Reduced 10.93%	93,680 $67.3 Million
Q1 2023 May 12, 2023	SELL	$680.49 - $826.97 $4.9 Million - $5.95 Million	-7,198 Reduced 6.41%	105,181 $86.4 Million
Q4 2022 Feb 14, 2023	SELL	$705.89 - $766.39 $4.39 Million - $4.76 Million	-6,215 Reduced 5.24%	112,379 $0
Q3 2022 Nov 04, 2022	SELL	$573.97 - $724.32 $1.04 Million - $1.31 Million	-1,806 Reduced 1.5%	118,594 $81.7 Million
Q2 2022 Aug 15, 2022	SELL	$548.35 - $738.84 $10.1 Million - $13.6 Million	-18,466 Reduced 13.3%	120,400 $71.7 Million
Q1 2022 May 13, 2022	SELL	$595.12 - $698.43 $51.7 Million - $60.7 Million	-86,956 Reduced 38.51%	138,866 $97 Million
Q4 2021 Feb 14, 2022	SELL	$543.48 - $670.97 $5.08 Million - $6.27 Million	-9,345 Reduced 3.97%	225,822 $146 Million
Q3 2021 Nov 15, 2021	BUY	$574.03 - $680.96 $38.3 Million - $45.4 Million	66,742 Added 39.63%	235,167 $142 Million
Q2 2021 Aug 16, 2021	SELL	$472.8 - $558.54 $1.48 Million - $1.75 Million	-3,137 Reduced 1.83%	168,425 $94.1 Million
Q1 2021 May 12, 2021	BUY	$446.73 - $548.2 $36.4 Million - $44.6 Million	81,374 Added 90.23%	171,562 $81.2 Million
Q4 2020 Feb 16, 2021	BUY	$478.3 - $607.98 $42.9 Million - $54.5 Million	89,604 Added 15343.15%	90,188 $43.6 Million
Q3 2020 Aug 05, 2021	SELL	$544.75 - $658.21 $108 Million - $130 Million	-197,941 Reduced 99.71%	584 $327,000
Q3 2020 Nov 16, 2020	BUY	$544.75 - $658.21 $108 Million - $130 Million	197,994 Added 37287.01%	198,525 $111 Million
Q2 2020 Aug 05, 2021	SELL	$493.32 - $643.92 $88.4 Million - $115 Million	-179,241 Reduced 99.7%	531 $331,000
Q2 2020 Aug 12, 2020	BUY	$493.32 - $643.92 $88.5 Million - $116 Million	179,407 Added 49152.6%	179,772 $112 Million
Q1 2020 Aug 05, 2021	SELL	$336.18 - $494.43 $37 Million - $54.4 Million	-109,966 Reduced 99.67%	365 $178,000
Q1 2020 May 12, 2020	BUY	$336.18 - $494.43 $37 Million - $54.4 Million	109,962 Added 29800.0%	110,331 $53.9 Million
Q4 2019 Aug 05, 2021	SELL	$274.13 - $376.51 $37.6 Million - $51.6 Million	-137,071 Reduced 99.73%	369 $139,000
Q4 2019 Feb 11, 2020	BUY	$274.13 - $376.51 $37.6 Million - $51.7 Million	137,231 Added 65660.77%	137,440 $51.6 Million
Q3 2019 Aug 05, 2021	SELL	$273.46 - $318.39 $40.3 Million - $47 Million	-147,526 Reduced 99.86%	209 $58,000
Q3 2019 Nov 13, 2019	BUY	$273.46 - $318.39 $40.4 Million - $47 Million	147,570 Added 89436.36%	147,735 $41 Million
Q2 2019 Aug 05, 2021	SELL	$299.6 - $414.82 $68.1 Million - $94.3 Million	-227,352 Reduced 99.93%	165 $52,000
Q2 2019 Aug 08, 2019	BUY	$299.6 - $414.82 $68.1 Million - $94.3 Million	227,360 Added 144815.3%	227,517 $0
Q1 2019 Aug 05, 2021	SELL	$372.08 - $439.57 $29.1 Million - $34.4 Million	-78,249 Reduced 99.8%	157 $64,000
Q1 2019 May 15, 2019	BUY	$372.08 - $439.57 $29.1 Million - $34.3 Million	78,100 Added 25522.88%	78,406 $0
Q4 2018 Aug 05, 2021	SELL	$335.82 - $403.04 $30.8 Million - $37 Million	-91,681 Reduced 99.67%	306 $114,000
Q4 2018 Feb 07, 2019	BUY	$335.82 - $403.04 $30.8 Million - $37 Million	91,853 Added 68547.01%	91,987 $34.4 Million
Q3 2018 Sep 01, 2021	SELL	$351.14 - $408.51 $29.5 Million - $34.3 Million	-83,894 Reduced 99.84%	134 $54,000
Q3 2018 Nov 07, 2018	BUY	$351.14 - $408.51 $29.5 Million - $34.3 Million	84,001 Added 311114.81%	84,028 $0
Q2 2018 Sep 01, 2021	SELL	$284.6 - $344.99 $24.2 Million - $29.3 Million	-85,058 Reduced 99.97%	27 $9,000
Q2 2018 Aug 13, 2018	BUY	$284.6 - $344.99 $24.2 Million - $29.3 Million	85,073 Added 708941.69%	85,085 $0
Q1 2018 Sep 01, 2021	SELL	$315.82 - $393.78 $27.1 Million - $33.8 Million	-85,926 Reduced 99.99%	12 $4,000
Q1 2018 May 04, 2018	SELL	$315.82 - $393.78 $13.4 Million - $16.7 Million	-42,425 Reduced 33.05%	85,938 $0
Q4 2017 Feb 13, 2018	BUY	$358.63 - $469.95 $1.32 Million - $1.73 Million	3,676 Added 2.95%	128,363 $48.4 Million
Q3 2017 Nov 02, 2017	BUY	$431.38 - $504.0 $53.8 Million - $62.8 Million	124,687	124,687 $55.8 Million

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.

Account

Prudential Financial Inc Regeneron Pharmaceuticals, Inc. Transaction History